Teva Pharmaceuticals
TEVA
TEVA
529 hedge funds and large institutions have $9.87B invested in Teva Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 86 funds opening new positions, 189 increasing their positions, 153 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
11% more funds holding
Funds holding: 477 → 529 (+52)
4% more funds holding in top 10
Funds holding in top 10: 24 → 25 (+1)
2.76% more ownership
Funds ownership: 50.9% → 53.66% (+2.8%)
Holders
529
Holding in Top 10
25
Calls
$577M
Puts
$124M
Top Buyers
| 1 | +$337M | |
| 2 | +$125M | |
| 3 | +$74.3M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$73.8M |
| 5 |
PC
PointState Capital
New York
|
+$65.7M |
Top Sellers
| 1 | -$149M | |
| 2 | -$109M | |
| 3 | -$54.3M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$47.1M |
| 5 |
Citigroup
New York
|
-$43.6M |